Status:
COMPLETED
Transcatheter Tricuspid Valve Interventions and Right Ventricular Function: Evaluation with Magnetic Resonance Imaging
Lead Sponsor:
Heart and Diabetes Center North-Rhine Westfalia
Conditions:
Tricuspid Valve Insufficiency
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
There is an urgent need for transcatheter tricuspid interventions, as pharmaceutical therapy becomes ineffective in advanced disease stages and surgery remains associated with high mortality rates. De...
Eligibility Criteria
Inclusion
- Patients with severe tricuspid regurgitation undergoing transcatheter tricuspid intervention.
Exclusion
- Patient with Incompatibility with magnetic resonance imaging or echocardiography
- Another valve disorder that requires treatment
- Severe precapillary pulmonary hypertension
- Unstable angina or percutaneous coronary intervention within the last 30 days
- Previous pacemaker/defibrillator implantation with intracardiac leads
- Patients with cardiac cachexia or a life expectancy less then 12 months
- Allergies to the material used.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 9 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04522154
Start Date
August 1 2020
End Date
March 9 2025
Last Update
March 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herz- und Diabeteszentrum, NRW
Bad Oeynhausen, North Rhine-Westphalia, Germany, 32545